Strata Critical Medical Income Statement Analysis

Revenue, earnings, and profit margins in millions USD

Scroll to see more
Strata Critical Medical, Inc. income statement - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022FY 2021
Period EndingDec 2024Dec 2023Dec 2022Sep 2021
Revenue & Gross Profit
Revenue248.69225.18146.1250.53
Cost of Revenue189.77183.06123.8540.01
Gross Profit58.9242.1222.2810.52
Operating Expenses
Research & Development3.184.635.551.68
Selling, General & Administrative82.42105.6170.2632.93
Operating Expenses85.61110.2475.8034.61
Operating Income-26.69-68.12-53.53-24.09
Other Income/Expense
Interest Income7.218.443.430.46
Interest Expense0.000.000.000.00
Other Income/Expense-0.85-2.1322.06-20.06
Income
Income Before Tax-27.56-57.54-28.03-43.70
Income Tax Expense-0.26-1.47-0.77-3.64
Net Income-27.31-56.08-27.26-40.05
Net Income - Continuous Operations-27.31-56.08-27.26-40.05
Net Income - Discontinued Operations0.000.000.000.00
EBITDA-20.73-58.87-47.80-23.50
EBIT-26.69-65.98-53.53-24.09
Depreciation & Amortization5.967.115.730.60
Earnings Per Share
Basic EPS--1.00--1.00
Diluted EPS--1.00--1.00
Basic Shares Outstanding77.5073.5271.6670.10
Diluted Shares Outstanding77.5073.5271.6670.10